'Get Your Skates On', UK Firms Planning M&A Warned

Act Now Before Regulatory Parting Of Ways, Says Legal Expert

UK pharma groups planning M&A deals ‘must get their skates on’ and begin filing now if they want to benefit from the EU’s review process before the Brexit transition period ends on 31 December.

Roller skates
UK Pharma M&A Process To Diverge From Single EU Route After 2020 • Source: Shutterstock

UK pharma groups with M&A plans need to act fast and start filing now if they want proposed deals cleared using the European Commission’s ‘one-stop-shop’ review process by the end of December, when the Brexit transition period ends, one M&A expert told Scrip.

John Schmidt, an antitrust lawyer and partner with Washington, DC-based Arnold & Porter, said that from 1 January 2021 there...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip